HAEMOCTIN subst sèche 250 UI c solv (5ml) flac

7680600940048 CH-60094 B02BD02 06.01.1.

Reimbursement limitations:

BLUTPRODUKTE

Calcul des prix des préparations sanguines sur la base du prix « ex factory », …

HAEMOCTIN subst sèche 250 UI c solv (5ml) flac
HAEMOCTIN subst sèche 250 UI c solv (5ml) flac
HAEMOCTIN subst sèche 250 UI c solv (5ml) flac
1 / 3
google

Details

Product number
6009401
CPT
-
Packaging group
1 + 1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: factor VIII coagulationis humanus 250 U.I., natrii chloridum, natrii citras dihydricus, calcii chloridum dihydricum, glycinum, pro vitro corresp. natrium 16.1 mg. Solvens: aqua ad iniectabile pro vitro, corresp. in solutione recenter reconstituta 100 U.I./ml.

Articles (1)

Haemoctin 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
1 + 1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
15/03/2021
Professional SmPC
Français
15/03/2021
Professional SmPC
Italien
15/03/2021

Detailed composition

Substance Quantity Type Category
PRC
250.0 UI Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HIMDK
PRC
16.1 MG Substance HBESI

Reimbursement information

Public price
CHF 216.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2011

Authorization holder

Biotest (Schweiz) AG

5102 Rupperswil

Authorization information

Swissmedic authorization number
60094
Drug name
Haemoctin, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULMJ
ATC Code
B02BD02
Authorization status
Z
Dispensation category
B
First authorization
19/08/2010
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Therapie und Prophylaxe von Blutungen bei Patienten mit Hämophilie A (angeborener Faktor-VIII-Mangel, erworbener Faktor-VIII-Mangel, Hämophilie A mit Auftreten von Faktor-VIII-Inhibitoren)

Packaging details

Description (FR)
HAEMOCTIN subst sèche 250 UI c solv (5ml) flac
Description (DE)
HAEMOCTIN Trockensub 250 IE c Solv (5ml) Durchstf
Market launch
19/08/2010
Narcotic (BTM)
No

Other packaging sizes

HAEMOCTIN subst sèche 500 UI c solv (5ml) flac
1 + 1 DUR
View
HAEMOCTIN subst sèche 1000 UI c solv (5ml) flac
1 + 1 DUR
View